Delivery Order SPE2DB22D3004-SPE2DB24FPY86
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,743.42 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Prolia 60 mg/mL syringes. The contract has an ultimate completion date of March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $1,620.86, is for the supply of Prolia 60 mg/mL syringes. It is a firm fixed-price contract with a period of performance through July 14, 2022. The contract was not set aside for any specific business category. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Prolia 60 mg/ml syringes. The $13,096.32 firm-fixed-price contract has a performance period through March 6, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
- This federal contract award, valued at $5,230.26, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of Prolia 60 mg/ml syringes, a specialty pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of PROLIA 60 MG/ML SYRINGEML, a pharmaceutical product, with an ultimate completion date of July 2, 2025 and a ceiling value of $22,182.71. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order valued at $18,297.65, is for the supply of PROLIA 60 MG/ML syringes. The contract has a period of performance through September 12, 2024 and is a Firm Fixed Price contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,226.07, is a delivery order for the supply of Prolia 60 mg/ml syringes. The contract has an ultimate completion date of April 15, 2025 and is a firm fixed-price contract. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Prolia 60 mg/ml syringes. The contract has a ceiling value of $8,828.08 and is a firm fixed-price, non-set-aside contract with a performance period through May 6, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Prolia 60 mg/ml syringes. The contract has a ceiling value of $14,623.18 and runs through July 25, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Prolia 60 mg/mL syringes. The order is valued at $3,486.84 and has a delivery date of August 8, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for providing a wide range of medical...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPY86Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of Prolia 60 mg/mL syringes, a specialty pharmaceutical product, with a ceiling value of $10,460.52 and a performance period through April 12, 2024. This is a firm fixed price delivery order contract, with no set-aside designation noted. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order is issued under that overarching IDC.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 4/11/24 |